Most bought healthcare stocks in Q4 2021
See which Healthcare stocks institutional investors increased the most in Q4 2021, measured as net growth in reported share positions from Q3 2021 into Q4 2021. Notable additions at the top of this list include ROIVANT SCIENCES LTD (ROIV), ELANCO ANIMAL HEALTH INC (ELAN), BOSTON SCIENTIFIC CORP (BSX), WEAVE COMMUNICATIONS INC (WEAV). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 88,271,900 | $889.78M | 2 | 0 | 0 | 0 | 2 |
| ELAN | ELANCO ANIMAL HEALTH INC | 18,411,102 | $494.60M | 0 | 4 | 2 | 1 | 6 |
| BSX | BOSTON SCIENTIFIC CORP | 12,095,021 | $492.45M | 0 | 3 | 3 | 0 | 7 |
| WEAV | WEAVE COMMUNICATIONS INC | 7,426,846 | $112.74M | 1 | 0 | 0 | 0 | 1 |
| TLRY | TILRAY BRANDS INC | 5,205,021 | $36.40M | 1 | 1 | 0 | 1 | 2 |
| OSCR | OSCAR HEALTH INC - CLASS A | 4,812,635 | -$45.02M | 3 | 1 | 1 | 0 | 6 |
| VTYX | VENTYX BIOSCIENCES INC | 4,312,834 | $83.08M | 1 | 0 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 3,850,358 | -$228.88M | 2 | 3 | 2 | 1 | 7 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 3,386,228 | -$47.78M | 0 | 1 | 0 | 1 | 2 |
| GILD | GILEAD SCIENCES INC | 3,361,216 | $403.03M | 0 | 6 | 7 | 0 | 13 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 3,228,142 | $86.56M | 0 | 3 | 0 | 0 | 3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,805,625 | $450.96M | 2 | 4 | 3 | 1 | 9 |
| ISRG | INTUITIVE SURGICAL INC | 2,757,035 | $116.22M | 1 | 10 | 0 | 1 | 11 |
| ARDX | ARDELYX INC | 2,040,421 | $2.24M | 1 | 0 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,945,554 | $841.06M | 4 | 7 | 3 | 0 | 18 |
| EXAS | EXACT SCIENCES CORP | 1,780,734 | -$70.18M | 0 | 4 | 1 | 0 | 5 |
| AVTR | AVANTOR INC | 1,737,254 | $103.31M | 0 | 4 | 0 | 0 | 5 |
| INMD | INMODE LTD SHS | 1,616,814 | $9.83M | 0 | 4 | 1 | 1 | 5 |
| SGRY | SURGERY PARTNERS INC | 1,606,631 | $85.95M | 1 | 1 | 0 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,475,532 | $46.73M | 0 | 4 | 0 | 0 | 4 |
| PRCT | PROCEPT BIOROBOTICS CORP | 1,239,735 | -$41.37M | 1 | 1 | 0 | 0 | 3 |
| VCYT | VERACYTE INC | 1,222,491 | $13.45M | 0 | 1 | 1 | 1 | 2 |
| XRAY | DENTSPLY SIRONA INC | 1,191,059 | $48.01M | 1 | 2 | 2 | 1 | 5 |
| ATOS | ATOSSA THERAPEUTICS INC | 1,170,340 | $1.87M | 1 | 0 | 0 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | 1,141,679 | $40.90M | 0 | 1 | 0 | 0 | 1 |
| OGN | ORGANON & CO | 1,096,580 | $25.09M | 1 | 2 | 6 | 1 | 10 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 1,052,589 | $3.08M | 3 | 0 | 0 | 0 | 3 |
| HYPR | HYPERFINE INC | 1,000,000 | $7.25M | 1 | 0 | 0 | 0 | 1 |
| MPLN | MULTIPLAN CORP | 984,892 | $4.34M | 0 | 1 | 0 | 0 | 1 |
| AMGN | AMGEN INC | 982,423 | $235.17M | 0 | 9 | 4 | 0 | 14 |
| BIIB | BIOGEN INC | 969,394 | $154.16M | 1 | 4 | 2 | 0 | 10 |
| EHC | ENCOMPASS HEALTH CORP | 878,539 | $55.25M | 2 | 3 | 0 | 0 | 5 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 839,447 | -$183.14M | 0 | 1 | 1 | 0 | 3 |
| MCRB | SERES THERAPEUTICS INC | 746,500 | $6.22M | 1 | 0 | 0 | 0 | 1 |
| HOLX | HOLOGIC INC | 744,492 | $70.62M | 1 | 3 | 3 | 0 | 7 |
| AIM | AIM IMMUNOTECH INC | 705,100 | $649.00K | 1 | 0 | 0 | 0 | 1 |
| AUPH | AURINIA PHARMACEUTICALS INC | 659,004 | $15.31M | 1 | 2 | 0 | 0 | 3 |
| SDGR | SCHRODINGER INC | 650,847 | -$161.32M | 0 | 1 | 1 | 0 | 3 |
| BDX | BECTON DICKINSON AND CO | 514,241 | $187.18M | 2 | 6 | 7 | 1 | 16 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 513,688 | $34.95M | 0 | 3 | 0 | 0 | 3 |
| PRGO | Perrigo Company PLC | 497,277 | -$6.31M | 2 | 1 | 0 | 0 | 4 |
| CTLT | CATALENT INC | 475,269 | $46.53M | 0 | 3 | 4 | 0 | 7 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 469,700 | $2.38M | 0 | 1 | 0 | 0 | 1 |
| ABCL | ABCELLERA BIOLOGICS INC | 454,903 | $2.23M | 0 | 1 | 0 | 0 | 2 |
| BFLY | BUTTERFLY NETWORK INC | 439,578 | -$24.03M | 1 | 2 | 0 | 0 | 3 |
| CRVS | CORVUS PHARMACEUTICALS INC | 430,362 | -$456.59K | 1 | 1 | 0 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 427,687 | $1.60M | 1 | 0 | 0 | 0 | 1 |
| DOCS | DOXIMITY INC-CLASS A | 414,687 | -$25.14M | 1 | 1 | 1 | 0 | 4 |
| CPRX | CATALYST PHARMACEUTICALS INC | 410,607 | $2.86M | 1 | 1 | 0 | 1 | 2 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 390,400 | $2.08M | 1 | 1 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q4 2021
What are the most bought Healthcare stocks in Q4 2021?
The most bought healthcare stocks in Q4 2021 are those with the largest increase in reported share counts across institutional investors compared to Q3 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2021?
Among filers in this sector, net additions were largest in companies such as ROIVANT SCIENCES LTD (ROIV), ELANCO ANIMAL HEALTH INC (ELAN), BOSTON SCIENTIFIC CORP (BSX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.